Search Within

Devyn Taylor Coskey

Formats
  1. Journal Article (8)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (16)
  2. Genitourinary Oncology Service (16)
  3. Solid Tumor Oncology Division (16)
  4. Department of Pathology and Laboratory Medicine (13)
  5. Biostatistics Service (12)
  6. Epidemiology and Biostatistics (12)

More Groups

People
  1. Darren Feldman (16)
  2. Martin Voss (16)
  3. Robert Motzer (15)
  4. Chung-Han Lee (13)
  5. Sujata Patil (12)
  6. Yingbei Chen (12)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (2)
  5. 2017 (4)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Clinical Genitourinary Cancer (2)
  3. BJU International (1)
  4. Cancer (1)
  5. European Urology (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Elsevier Inc. (2)
  3. Wiley Blackwell (2)
  4. American Medical Association (1)
  5. Elsevier Science, Inc. (1)
  6. IOS Press (1)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes
    Meeting Abstract

    Lee, C. H.; Carlo, M.; Chen, Y.; Chaim, J.; Coskey, D.; Woo, K.; Voss, M.; Hsieh, J.; Feldman, D.; Motzer, R.
    BJU International (2016)

    Fulltext@MSK | Save
  • Phase II trial and correlative genomic analysis of everolimus plus bevacizumab in advanced non-clear cell renal cell carcinoma
    Journal Article

    Voss, M. H.; Molina, A. M.; Chen, Y. B.; Woo, K. M.; Chaim, J. L.; Coskey, D. T.; Redzematovic, A.; Wang, P.; Lee, W.; Selcuklu, S. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Bevacizumab monotherapy as salvage therapy for advanced clear cell renal cell carcinoma pretreated with targeted drugs
    Journal Article

    Lee, C. H.; Hötker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K. M.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J. J.; Motzer, R. J.
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • A phase II trial of everolimus (E) and bevacizumab (B) in advanced non-clear cell renal cell cancer (ncRCC) to show efficacy in patients (pts) with papillary features
    Meeting Abstract

    Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Redzematovic, A.; Wang, P.; Lee, W.; Patil, S.; Molina, A. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II trial of everolimus and bevacizumab in advanced non-clear cell renal cell cancer
    Meeting Abstract

    Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Patil, S.; Molina, A. M.; Hsieh, J.; Motzer, R. J.; Feldman, D. R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Bevacizumab monotherapy as salvage therapy for patients with advanced clear cell renal cell carcinoma pretreated with targeted drugs
    Meeting Abstract

    Lee, C. H.; Hoetker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J.; Motzer, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save